Adenosine receptor targeting in health and disease

Author： Gessi Stefania   Merighi Stefania   Fazzi Debora   Stefanelli Angela   Varani Katia   Borea Pier Andrea  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.12, 2011-12, pp. : 1591-1609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational A3 adenosine receptor targeting agents

By Koscsó Balázs   Csóka Balázs   Pacher Pál   Haskó György  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 757-768

Informa Healthcare

Access to resources Recommend Favorite

Targeting the mineralocorticoid receptor in cardiovascular disease

By Young Morag J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 321-331

Informa Healthcare

Access to resources Recommend Favorite

Targeting the thyrotropin receptor in thyroid disease

By El-Kaissi Samer   Wall Jack R  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 719-727

Informa Healthcare

Access to resources Recommend Favorite

Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation

By Eltzschig Holger K   Rivera-Nieves Jesus   Colgan Sean P  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1267-1277

Informa Healthcare

Access to resources Recommend Favorite

Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists

By Szabóó Nikoletta   Kincses Zsigmond Tamáás   Véécsei Láászlóó  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite